1 - 5 of 5 results (0.59 seconds)
Sort By:
  • Climate Risk Analysis for Life and Health Insurance Companies
    Climate Risk Analysis for Life and Health Insurance Companies On March 31, 2022, the SOA Research ... were encouraged to contribute from their own, individual perspective working in areas such as insurance ...

    View Description

    • Authors: Didier Serre
    • Date: Jun 2022
    • Competency: External Forces & Industry Knowledge
    • Topics: Actuarial Profession; Environment
  • Climate Risk Analysis for Life and Health Insurance Companies
    were encouraged to contribute from their own, individual perspective working in areas such as insurance ... were encouraged to contribute from their own, individual perspective working in areas such as insurance ...

    View Description

    • Authors: Didier Serre
    • Date: Jun 2022
    • Competency: External Forces & Industry Knowledge
    • Topics: Actuarial Profession; Environment
  • Evaluating Payment Models for High-Cost Curative Therapies
    the strengths and weaknesses of each approach. Table 1 presents the assessment results from this study ... 7 Copyright © 2018 Society of Actuaries Table 1 Core Criteria-Based Assessment of Payment Models ...

    View Description

    • Authors: Didier Serre, Joanne L Buckle, Jessica Marie Naber, Anne M Jackson
    • Date: Oct 2018
    • Competency: External Forces & Industry Knowledge
    • Topics: Health & Disability>Health care; Health & Disability>Payment models
  • New Report on Evaluating Payment Models for High-Cost Curative Therapies
    New Report on Evaluating Payment Models for High-Cost Curative Therapies This short article presents ... framework (see Table 5). These apply to single-payer and multipayer systems. Table 5 Core Evaluation ...

    View Description

    • Authors: Didier Serre
    • Date: Mar 2019
    • Competency: Technical Skills & Analytical Problem Solving>Innovative solutions
    • Publication Name: Health Watch
    • Topics: Health & Disability>Payment models
  • Genomic Testing: Cost-Saving or Cost-Inflating for Payers?
    these gene- profiling tests. The two scenarios in Table 1 assume that all patients in the high clinical ... or cost- inflating. The hypothetical example in Table  2 illustrates how selecting 100 patients at random ...

    View Description

    • Authors: Didier Serre
    • Date: Feb 2018
    • Competency: External Forces & Industry Knowledge>Actuarial methods in business operations; Results-Oriented Solutions>Assess decision effectiveness
    • Publication Name: Health Watch
    • Topics: Health & Disability>Health care